A Randomized, Clinical Study to evaluate the Efficacy and Safety of Polyherbal Unani Formulation in Acne Vulgaris.
Phase 2
- Conditions
- Health Condition 1: L700- Acne vulgaris
- Registration Number
- CTRI/2023/03/050164
- Lead Sponsor
- ational Research Institute of Unani Medicine for Skin Disorders
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Clinically stable patients
2. Patient having chronicity 4 months to 1 year
3. Patients having the following symptoms of Buthur Labaniyya:
Comedones
Papules
Pustules
Nodules
Itching
Erythema
Exclusion Criteria
1. Patients aged <15 years or >35 years
2. Pregnant or Lactating Women
3. Patients on corticosteroid or anticonvulsant therapy or taking oral contraceptives
4. Patients suffering from other concomitant diseases, like acne rosacea, acne fulminans, acne necrotica, psoriasis, eczema, etc.
5. Significant Pulmonary/Cardiovascular/Hepato-renal Dysfunction
6. Patient not willing to attend treatment schedules regularly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome measure will be assessed using following parameters: <br/ ><br>1. Reduction in Global Acne Grading System <br/ ><br>2. Reduction in Cooks Acne Grading Scale <br/ ><br>3. Reduction in Dermatology Life Quality Index <br/ ><br>4. Improvement in Visual Analogue Scale.Timepoint: 42 days
- Secondary Outcome Measures
Name Time Method Systemic Safety AssessmentTimepoint: 42 days